Cincinnati Children’s is one of four sites in the U.S. participating in a Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The other three testing sites in the U.S. include the NYU Grossman School of Medicine, the University of Maryland School of Medicine, and the University of Rochester Medical Center/Rochester Regional Health. Read more here.